(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 16.44% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Inspire Medical Systems's revenue in 2024 is $705,705,000.On average, 8 Wall Street analysts forecast INSP's revenue for 2024 to be $23,742,164,346, with the lowest INSP revenue forecast at $23,678,435,358, and the highest INSP revenue forecast at $23,806,072,264. On average, 8 Wall Street analysts forecast INSP's revenue for 2025 to be $28,134,752,678, with the lowest INSP revenue forecast at $26,858,920,410, and the highest INSP revenue forecast at $28,539,373,599.
In 2026, INSP is forecast to generate $33,379,287,537 in revenue, with the lowest revenue forecast at $32,326,730,388 and the highest revenue forecast at $34,482,839,804.